RE:RE:RE:RE:CBD, cannibal market, outlook USA.
What LABS needs, and frankly has always needed since their pivot, is evidence of progress. No doubt the idea of being the supplier of choice to billion dollar pharmas is one that sets our dreams a-light, but scaping in a few million a quarter just isn't cutting it. Does it take time to grow a business, yes....but LABS (through their apparent vast international network of partners) ought to be showing a material change by now....and both insititional and average joe investors alike are getting bored and fed up. It's pretty damning when an ETF manager decides they've had it when the SP is already pretty much zero and are willing to take a loss to exit. I'm still fully invested (pretty much because there's no reason to exit for pennies any longer) but am not at all happy with the lack of progress on any real front. I hope I'm proven wrong...but so far nothing is looking up at the moment, and that's just sad.